CGM

An image of the pre-acquisition InPen device and connected app.

The InPen alongside Companion Medical's connected app

By Dave Muoio 01:56 pm November 12, 2020
Shortly after acquiring smart insulin-pen-maker Companion Medical, Medtronic has officially launched the InPen device alongside integration with its Guardian Connect connected glucose monitoring (CGM) system. Of note, Medtronic's InPen is the only smart insulin pen cleared by the FDA for use by people requiring multiple daily injections. It received that 510(k) back in 2016. WHY IT MATTERS With...
By Dave Muoio 11:36 am September 2, 2020
Abbott announced yesterday that its recently cleared FreeStyle Libre 2 integrated continuous glucose monitoring (CGM) system is now covered by the Centers for Medicare and Medicaid Services (CMS), and available to Medicare beneficiaries with diabetes who meet eligibility criteria. Indicated for diabetes management in patients aged four years or older, the updated version of Abbott's system can...
By Dave Muoio 11:57 am August 11, 2020
Continuous glucose monitoring (CGM) system-maker Senseonics has cut a deal with Ascensia Diabetes Care and its parent company, PHC Holdings, outlining commercialization and distribution of the Eversense product line over the next few years. According to the companies, Ascensia now holds exclusive global distribution rights for the Eversense, Eversense XL and future CGMs. The duration of the...
By Mallory Hackett 12:44 pm July 31, 2020
Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday. Despite having some uncertainty in the impacts of the COVID-19 pandemic, Dexcom was able to produce significant year-over-year growth in Q2 2020. Sayer attributes much of the growth to a steady increase in knowledge...
By Laura Lovett 02:04 pm July 27, 2020
This morning Belgian startup Indigo Diabetes announced a €38 million ($44.6 million) Series B funding round. This round included contributions from new investors Fund+, Ackermans&van Haaren, Capricorn Digital Growth Fund, imec.xpand and Titan Baratto.  The latest round comes roughly two years after the Ghent University-spinout announced a €7.1 million ($8.2 million) Series A round led by...
By Dave Muoio 09:06 am July 14, 2020
This morning continuous glucose monitor (CGM) startup Movano Inc. exited stealth with the news of $10 million bridge funding round headed by Tri-Valley Ventures. Taken alongside its prior investments, the company said it has now raised $27 million since its founding in 2018. WHAT THEY DO Movano is developing a connected CGM wearable that doesn't require the user to break the skin with a needle or...
By Dave Muoio 02:48 pm July 13, 2020
UnitedHealth Group announced plans this morning to distribute a device-driven diabetes management model to 230,000 employer-sponsored members with Type 2 diabetes at no additional cost. The pilot program, called Level2 by UnitedHealthcare, provides members with a Dexcom G6 continuous glucose monitor (CGM) that connects to their smartphone, a Fitbit activity tracker, personalized coaching and...
By Laura Lovett 03:15 pm June 15, 2020
This morning Abbott revealed that its much anticipated integrated continuous glucose monitoring system the FreeStyle Libre 2 is now FDA cleared for adults and kids over the age of 4 with diabetes.  The latest product is able to continuously transmit glucose data every minute, and users can set the system to send alarms when their glucose is too high or too low. Previously users had to scan the...
By Dave Muoio 02:37 pm June 15, 2020
The American Diabetes Association's 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers and service providers highlighted new data as part of the virtual clinical conference. Read on for summaries of the studies and findings, as well as links to the online abstracts. Onduo Verily-backed diabetes management service Onduo, which combines a mobile app...
By Mallory Hackett 09:54 am June 9, 2020
A new study published in US Endocrinology found Abbott’s continuous glucose monitoring system, the FreeStyle Libre, demonstrated significant cost savings for diabetic care compared to traditional fingerstick testing.  Abbott’s system uses flash continuous glucose monitoring (CGM) through a sensor placed to the back of the upper arm, and lasts for up to 14 days. The device automatically collects...